The Autoimmune Polyglandular Syndrome Type 1 (APS-1) Market is an emerging segment within the rare autoimmune disease landscape. APS-1, also known as Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED), is a monogenic, inherited disorder caused by mutations in the AIRE gene. It manifests with multiple endocrine and non-endocrine autoimmune conditions, including...